Skip to main content

Table 1 Demographic and clinical characteristics of patients with IBS and SIBO

From: Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?

Characteristics

All patients (N = 98)

IBS with SIBO (n = 35)

Odds ratio* (95% CI)

Age >55 y, n (%)

28 (29)

16 (46)

3.6 (1.4-9.0)

Female, n (%)

76 (78)

32 (91)

4.0 (1.1-14.5)

IBS subtype, n (%)

   

   IBS-C

51 (52)

19 (54)

1.2 (0.5-2.6)

   IBS-D

38 (39)

15 (43)

1.3 (0.6-3.0)

   IBS-A

9 (9)

1 (3)

0.2 (0.02-1.7)

Medications,** n (%)

   

   Tegaserod

15 (15)

6 (17)

1.1 (0.4-3.3)

   Opiate analgesic

38 (39)

13 (37)

1.0 (0.4-2.3)

   Proton pump inhibitor

21 (21)

7 (20)

0.8 (0.3-2.1)

  1. IBS: irritable bowel syndrome; SIBO: small intestinal bacterial overgrowth; CI: confidence interval; IBS-C: constipation-predominant IBS; IBS-D: diarrhea-predominant IBS; IBS-A: alternating IBS.
  2. *Comparing patients with IBS versus patients with IBS and SIBO, **Previous and current use of specific IBS therapy.